The trademark application was filed by D3 Bio (Wuxi) Co., Ltd., a corporation established under the laws of the People's Republic of China (the "Applicant"). The application was published for oppositions on September 1, 2021, and it was registered by office on December 9, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations
Chemico-pharmaceutical preparations
Drugs for medical purposes
Biomedicine
Drugs for the treatment of respiratory diseases
Drugs for cancer
Drugs for treating viral disease
Pharmaceutical preparation for treating musculoskeletal disorders
Pharmaceutical preparation for treating gastrointestinal disease
Pharmaceutical preparation for treating diseases and disorders related to the immune system
Pharmaceutical preparation for the central nervous system